Aβ Oligomers Cause Localized Ca 2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines
Open accessAbstract
Aggregation of amyloid-β (Aβ) and Tau protein are hallmarks of Alzheimer's disease (AD), and according to the Aβ-cascade hypothesis, Aβ is considered toxic for neurons and Tau a downstream target of Aβ. We have investigated differentiated primary hippocampal neurons for early localized changes following exposure to Aβ oligomers. Initial events become evident by missorting of endogenous Tau into the somatodendritic compartment, in contrast to axonal sorting in normal neurons. In missorted dendritic regions there is a depletion of spines and local increase in Ca 2+ , and breakdown of microtubules. Tau in these regions shows elevated phosphorylation at certain sites diagnostic of AD-Tau (e.g., epitope of antibody 12E8, whose phosphorylation causes detachment of Tau from microtubules, and AT8 epitope), and local elevation of certain kinase activities (e.g., MARK/par-1, BRSK/SADK, p70S6K, cdk5, but not GSK3β, JNK, MAPK). These local effects occur without global changes in Tau, tubulin, or kinase levels. Somatodendritic missorting occurs not only with Tau, but also with other axonal proteins such as neurofilaments, and correlates with pronounced depletion of microtubules and mitochondria. The Aβ-induced effects on microtubule and mitochondria depletion, Tau missorting, and loss of spines are prevented by taxol, indicating that Aβ-induced microtubule destabilization and corresponding traffic defects are key factors in incipient degeneration. By contrast, the rise in Ca 2+ levels, kinase activities, and Tau phosphorylation cannot be prevented by taxol. Incipient and local changes similar to those of Aβ oligomers can be evoked by cell stressors (e.g., H 2 O 2 , glutamate, serum deprivation), suggesting some common mechanism of signaling.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Aβ oligomers mis-localize to dendrites and spines causing neurotoxicity.
“mis-localization to dendrites and spines causing neurotoxicity [52]”
From Astrocytic APOE3-Christchurch expression ameliorates brain amyloid-β pathology in 5xFAD mice (2026) · cites this paper as [52]
The section ‘Aβ oligomers induce missorting of Tau’ reports that Aβ oligomers localize to dendrites, particularly spines, and that exposure causes harmful changes including spine loss. But it identifies Tau—not Aβ oligomers—as the protein that is missorted into dendrites; it does not establish that the oligomers themselves are mislocalized. No page number is available in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredUnder normal conditions, tau is primarily localized to axons and promotes formation and stabilization of microtubules.
“Under normal conditions, tau is primarily localized to axons and promotes formation and stabilization of microtubules; however, in AD, tau becomes hyperphosphorylated and mislocalizes to somatodendritic compartments (Avila et al., 2004, Ittner et al., 2010, Zempel et al., 2010).”
From Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice (2021) · cites this paper as Zempel et al., 2010
The Figure 3 caption (Discussion; page unavailable) says tau is predominantly axonal in control neurons. The Discussion links tau’s detachment from microtubules to their destabilization, supporting a stabilizing role, but our copy does not establish the claim that tau promotes microtubule formation. (LLM, conf=0.82)
Experimental — accuracy not yet measuredActivities of GSK3 and PAR-1/MARKs are often associated with tau detachment from microtubules and Aβ-induced augmentation of tau toxicity.
“the activities of two major tau kinases, GSK3 and PAR-1/microtubule affinity-regulating kinases (MARKs), are often associated with tau detachment from microtubules and Aβ-induced augmentation of tau toxicity [37, 39, 43–45].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
In the Discussion and Figure 6, the paper links Aβ-induced MARK/Par-1 activity to tau detachment from microtubules and microtubule destabilization. It does not support the same association for GSK3β in this experiment: the Discussion says GSK3β activity did not increase in dendrites with missorted tau. (LLM, conf=0.88)
Experimental — accuracy not yet measuredStudies in cultured neurons and transgenic Drosophila showed that Aβ-induced augmentation of tau toxicity depends on tau phosphorylation at these sites.
“Notably, studies in cultured neurons and transgenic Drosophila showed that Aβ-induced augmentation of tau toxicity caused by Aβ depends on tau phosphorylation at these sites [39, 45, 56–58].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
The results section (page unavailable) reports increased tau phosphorylation at pS262/pS356 and pS202/pT205 in Aβ-exposed cultured hippocampal neurons. It does not report a transgenic Drosophila experiment or establish that phosphorylation at those sites is required for Aβ-induced augmentation of tau toxicity. (LLM, conf=0.85)
Experimental — accuracy not yet measuredAβ promotes tau phosphorylation at disease-associated sites in in vitro and in vivo models of AD.
“Aβ promotes tau phosphorylation at disease-associated sites in in vitro and in vivo models of AD [2, 35–41].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
The Abstract and Figure 5 passage report that Aβ oligomers increased tau phosphorylation at AD-associated epitopes, including 12E8 and AT8, in cultured hippocampal neurons. The paper’s experimental model was in vitro; it does not establish the claimed effect in an in vivo model. (LLM, conf=0.88)
Experimental — accuracy not yet measured
In cellular and animal models, co-expression of Aβ augments tau phosphorylation at these sites and increases the levels of active GSK3 and PAR-1/MARK.
“In cellular and animal models, co-expression of Aβ augments tau phosphorylation at these sites and increases the levels of active GSK3 and PAR-1/MARK [2, 35–41, 43, 44].”
From Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity (2016) · cites this paper as [39]
In “Synapses disappear in regions of Tau missorting” (page unavailable), the paper reports increased Tau phosphorylation and strong local activation of MARK after Aβ-oligomer treatment. It explicitly says GSK3β activity remained unchanged. The experiments described used treated cultured neurons, not co-expression of Aβ in both cellular and animal models. (LLM, conf=0.90)
Experimental — accuracy not yet measuredAb oligomers cause tau mislocalization.
“Ab oligomers also cause tau mislocalization (77,78).”
In Alzheimer's disease, tau becomes hyperphosphorylated and mislocalizes to somatodendritic compartments.
“Under normal conditions, tau is primarily localized to axons and promotes formation and stabilization of microtubules; however, in AD, tau becomes hyperphosphorylated and mislocalizes to somatodendritic compartments (Avila et al., 2004, Ittner et al., 2010, Zempel et al., 2010).”
From Dendritic Spine Remodeling and Synaptic Tau Levels in PS19 Tauopathy Mice (2021) · cites this paper as Zempel et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · cited 1× · see citing works
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundRetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · cited 1× · see citing works
“Despite numerous studies on the pathway of APP misprocessing and its consequences for neurons the modes of A toxicity have remained enigmatic (Haass and Selkoe, 2007; Small and Duff, 2008).”
BackgroundCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064 · cited 1× · see citing works
“Nevertheless, there were differences in structure because dot blots with antibody A11, which recognizes a more toxic generic amyloid conformation (Kayed et al., 2003), were more intense for F12 medium than for Nb (Fig.”
BackgroundLambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · cited 3× · see citing works
“There is a moderate decrease of ATP which is more apparent with F12 than with Nb medium, suggesting that F12, which was used in the original procedure (Lambert et al., 1998), could have some toxic effects on its own.”
BackgroundMethodTau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174 · cited 1× · see citing works
“These include loss of synapses and neurons, deficiency in neurotransmitters and metabolism, aggregation of amyloid- (A )-peptides into extracellular “amyloid plaques” and Tau protein into intracellular “neurofibrillary tangles” (Selkoe, 2004; Binder et al., 2005; Ballatore et al., 2007).”
BackgroundReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1× · see citing works
“…conversely Tau is considered necessary for the progression of neurodegeneration, as seen in cell and animal models (Rapoport et al., 2002; King et al., 2006; Roberson et al., 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and Braak, 1991; Clavaguera et al., 2009).”
BackgroundTransmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803 · see citing works
Shankar, G. M., Bloodgood, B. L., Townsend, M., Walsh, D. M., Selkoe, D. J., & Sabatini, B. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4970-06.2007 · Cited by 1,592 · cited 1× · see citing works
“4e,f), and involving NMDA receptors and others (De Felice et al., 2007; Shankar et al., 2007).”
BackgroundPhysiology and Pathophysiology of Purinergic Neurotransmission
Burnstock, G. (2007) · Physiological Reviews · doi:10.1152/physrev.00043.2006 · Cited by 1,579 · cited 1× · see citing works
“We also tested extracellular ATP (100 M, 3 h), which functions as a stress signal and induces Ca 2 influx via P2 receptors and has been implicated in neurodegenerative disease (Burnstock, 2007).”
MethodThe axonal transport of mitochondria
Saxton, W. M., & Hollenbeck, P. J. (2012) · Journal of Cell Science · doi:10.1242/jcs.053850 · Cited by 1,198 · cited 1× · see citing works
“As shown previously (Stamer et al., 2002; Hollenbeck and Saxton, 2005; Thies and Mandelkow, 2007), such mitochondrial traffic jams cause a local drop of energy (ATP) and consequently spine destruction through the perturbation of the actin network and loss of synaptic components (Whiteman et al.,…”
BackgroundPain: Moving from Symptom Control toward Mechanism-Specific Pharmacologic Management
Woolf, C. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00010 · Cited by 1,134 · see citing works
Microtubule assembly, organization and dynamics in axons and dendrites
Conde, C., & Cáceres, A. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2631 · Cited by 1,086 · cited 1× · see citing works
“In addition a change in MT dynamics alters their posttranslational modifications and thus perturbs polarized trafficking of cargo (Li and Gundersen, 2008; Conde and Cáceres, 2009; Konishi and Setou, 2009).”
BackgroundNeurotoxicity of a Fragment of the Amyloid Precursor Associated with Alzheimer's Disease
Yankner, B. A., Dawes, L. R., Fisher, S., Villa-Komaroff, L., Oster-Granite, M. L., & Neve, R. L. (1989) · Science · doi:10.1126/science.2474201 · Cited by 907 · cited 2× · see citing works
“Previous studies have focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to…”
BackgroundStamer, K., Vogel, R., Thies, E., Mandelkow, E., & Mandelkow, E.-M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108057 · Cited by 885 · cited 2× · see citing works
“As shown previously (Stamer et al., 2002; Hollenbeck and Saxton, 2005; Thies and Mandelkow, 2007), such mitochondrial traffic jams cause a local drop of energy (ATP) and consequently spine destruction through the perturbation of the actin network and loss of synaptic components (Whiteman et al.,…”
BackgroundSelf-citationDe Felice, F. G., Velasco, P. T., Lambert, M. P., Viola, K., Fernandez, S. J., Ferreira, S. T., & Klein, W. L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607483200 · Cited by 882 · cited 1× · see citing works
“4e,f), and involving NMDA receptors and others (De Felice et al., 2007; Shankar et al., 2007).”
BackgroundThe Mechanism of Ca2+-Dependent Regulation of Kinesin-Mediated Mitochondrial Motility
Wang, X., & Schwarz, T. L. (2009) · Cell · doi:10.1016/j.cell.2008.11.046 · Cited by 871 · cited 2× · see citing works
“Thirdly, Ca 2 uncouples mitochondrial motors from microtubule tracks (Wang and Schwarz, 2009).”
BackgroundBernstein, S. L., Dupuis, N., Lazo, N., Wyttenbach, T., Condron, M., Bitan, G., Teplow, D., Shea, J., Ruotolo, B., Robinson, C., et al. (2009) · Nature Chemistry · doi:10.1038/nchem.247 · Cited by 847 · cited 1× · see citing works
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundTau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807 · cited 1× · see citing works
“…upstream of changes in Tau, but conversely Tau is considered necessary for the progression of neurodegeneration, as seen in cell and animal models (Rapoport et al., 2002; King et al., 2006; Roberson et al., 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and…”
BackgroundStructural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783 · cited 5× · see citing works
“On the SDS gels, the different media (F12 or Nb) yielded similar bands, with the caveat that these gels can obscure the coexistence of multiple oligomeric species (Glabe, 2008).”
BackgroundInfluentialKöpke, E., Tung, Y. C., Shaikh, S., Alonso, A. C., Iqbal, K., & Grundke-Iqbal, I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80536-5 · Cited by 779 · see citing works
Structure–neurotoxicity relationships of amyloid β-protein oligomers
Ono, K., Condron, M. M., & Teplow, D. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905127106 · Cited by 774 · cited 2× · see citing works
“We note that, apart from its minor amount, the fiber component would be of lesser importance since its toxicity is lower than that of oligomers (Klein et al., 2004; Ono et al., 2009).”
BackgroundResultKayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773 · see citing works
Mattson, M. P. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00275.x · Cited by 751 · cited 2× · see citing works
“, proteasome, mitochondria) and perturbation of calcium homeostasis (Mattson, 2007).”
BackgroundAnimal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · cited 2× · see citing works
“Examples of local effects are the early loss of synapses and the appearance of Tau in somata and dendrites (Götz and Ittner, 2008).”
BackgroundDemonstration of amyloid deposits and neurofibrillary changes in whole brain sections
Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598 · cited 2× · see citing works
“The neurofibrillary changes follow a typical pathway of spreading which corresponds to clinical symptoms, hence Tau pathology is considered as one of the culprits in the disease (Braak and Braak, 1991; Spires-Jones et al., 2009).”
Backgroundβ-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595 · cited 1× · see citing works
“…focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to Tau redistribution.”
BackgroundLinking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · cited 1× · see citing works
“Despite numerous studies on the pathway of APP misprocessing and its consequences for neurons the modes of A toxicity have remained enigmatic (Haass and Selkoe, 2007; Small and Duff, 2008).”
BackgroundKlein, W. L., Stine, W. B., & Teplow, D. B. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.010 · Cited by 487 · cited 3× · see citing works
“We note that, apart from its minor amount, the fiber component would be of lesser importance since its toxicity is lower than that of oligomers (Klein et al., 2004; Ono et al., 2009).”
BackgroundMethodIntroducing intermediate filaments: from discovery to disease.
Eriksson, J., Dechat, T., Grin, B., Helfand, B., Mendez, M. G., Pallari, H.-M., & Goldman, R. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38339 · Cited by 463 · cited 1× · see citing works
“An additional function of microtubules is to subtend cellular networks such as the ER and intermediate filament network, so that these networks collapse when microtubules or motors are inactivated or reversed in direction (Stamer et al., 2002; Eriksson et al., 2009).”
BackgroundTau, tangles, and Alzheimer's disease.
Binder, L., Guillozet-Bongaarts, A. L., García-Sierra, F., & Berry, R. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2004.08.014 · Cited by 443 · cited 1× · see citing works
“These include loss of synapses and neurons, deficiency in neurotransmitters and metabolism, aggregation of amyloid- (A )-peptides into extracellular “amyloid plaques” and Tau protein into intracellular “neurofibrillary tangles” (Selkoe, 2004; Binder et al., 2005; Ballatore et al., 2007).”
BackgroundTubulin tyrosination navigates the kinesin-1 motor domain to axons
Konishi, Y., & Setou, M. (2009) · Nature Neuroscience · doi:10.1038/nn.2314 · Cited by 415 · cited 1× · see citing works
“In addition a change in MT dynamics alters their posttranslational modifications and thus perturbs polarized trafficking of cargo (Li and Gundersen, 2008; Conde and Cáceres, 2009; Konishi and Setou, 2009).”
BackgroundZhang, B., Maiti, A., Shively, S., Lakhani, F., McDonald-Jones, G., Bruce, J., Lee, E. B., Xie, S. X., Joyce, S., Li, C., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406361102 · Cited by 413 · cited 1× · see citing works
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundBeyond polymer polarity: how the cytoskeleton builds a polarized cell
Li, R., & Gundersen, G. G. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2522 · Cited by 372 · cited 1× · see citing works
“In addition a change in MT dynamics alters their posttranslational modifications and thus perturbs polarized trafficking of cargo (Li and Gundersen, 2008; Conde and Cáceres, 2009; Konishi and Setou, 2009).”
BackgroundWu, H.-Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z., Spires-Jones, T., Xie, H., Arbel-Ornath, M., Grosskreutz, C. L., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-09.2010 · Cited by 367 · cited 1× · see citing works
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
BackgroundMammalian SAD Kinases Are Required for Neuronal Polarization
Kishi, M., Pan, Y. A., Crump, J. G., & Sanes, J. R. (2005) · Science · doi:10.1126/science.1107403 · Cited by 343 · cited 1× · see citing works
“6c); this kinase, like MARK, is involved in axonal differentiation (Kishi et al., 2005) and also belongs to the AMPK family of kinases.”
BackgroundTau pathophysiology in neurodegeneration: a tangled issue
Spires‐Jones, T. L., Stoothoff, W. H., de Calignon, A., Jones, P., & Hyman, B. T. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.007 · Cited by 316 · cited 1× · see citing works
“The neurofibrillary changes follow a typical pathway of spreading which corresponds to clinical symptoms, hence Tau pathology is considered as one of the culprits in the disease (Braak and Braak, 1991; Spires-Jones et al., 2009).”
BackgroundThies, E., & Mandelkow, E.-M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4674-06.2007 · Cited by 293 · cited 3× · see citing works
“Earlier experiments with overexpressed Tau had shown that dendritic Tau can cause traffic jams, resulting in transport inhibition of vesicles and organelles (e.g., mito- chondria), loss of ATP supply, and decay of synaptic spines (Thies and Mandelkow, 2007).”
BackgroundSelf-citationMattson, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90447-n · Cited by 292 · cited 1× · see citing works
“…have focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to Tau…”
BackgroundProtein Kinase MARK/PAR-1 Is Required for Neurite Outgrowth and Establishment of Neuronal Polarity
Biernat, J., Wu, Y.-Z., Timm, T., Zheng-Fischhöfer, Q., Mandelkow, E., Meijer, L., & Mandelkow, E.-M. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-03-0046 · Cited by 279 · cited 1× · see citing works
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
BackgroundSelf-citationPark, S.-Y., & Ferreira, A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-05.2005 · Cited by 262 · cited 1× · see citing works
“…focused primarily on global effects of A on changes in Tau (e.g., phosphorylation, cleavage) and resulting cell death (Yankner et al., 1989; Mattson, 1990; Busciglio et al., 1995; Park and Ferreira, 2005; King et al., 2006), with less attention to the localized changes due to Tau redistribution.”
BackgroundCalcium lability of cytoplasmic microtubules and its modulation by microtubule-associated proteins.
Schliwa, M., Euteneuer, U., Bulinski, J. C., & Izant, J. G. (1981) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.78.2.1037 · Cited by 239 · cited 3× · see citing works
“and promotes their disassembly (Schliwa et al., 1981); this mechanism operates in addition to the Ca 2 -CaM-dependent”
BackgroundMethodInfluentialAlzheimer Disease: Mechanistic Understanding Predicts Novel Therapies
Selkoe, D. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-8-200404200-00046 · Cited by 234 · cited 1×
“These include loss of synapses and neurons, deficiency in neurotransmitters and metabolism, aggregation of amyloid- (A )-peptides into extracellular “amyloid plaques” and Tau protein into intracellular “neurofibrillary tangles” (Selkoe, 2004; Binder et al., 2005; Ballatore et al., 2007).”
BackgroundWogulis, M., Wright, S., Cunningham, D., Chilcote, T., Powell, K., & Rydel, R. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2381-04.2005 · Cited by 233 · cited 2× · see citing works
“This can be done in a variety of ways, and there is a debate on which is most appropriate for assessing A toxicity (Wogulis et al., 2005).”
BackgroundWalsh, D. M., Klyubin, I., Shankar, G. M., Townsend, M., Fadeeva, J. V., Betts, V., Podlisny, M. B., Cleary, J. P., Ashe, K. H., Rowan, M. J., et al. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051087 · Cited by 220 · cited 1× · see citing works
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundTau-dependent microtubule disassembly initiated by prefibrillar β-amyloid
King, M. E., Kan, H.-M., Baas, P. W., Erişir, A., Glabe, C. G., & Bloom, G. S. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605187 · Cited by 215 · cited 2× · see citing works
“…Tau, but conversely Tau is considered necessary for the progression of neurodegeneration, as seen in cell and animal models (Rapoport et al., 2002; King et al., 2006; Roberson et al., 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and Braak, 1991; Clavaguera et…”
BackgroundLovell, M., Xiong, S., Xie, C.-S., Davies, P., & Markesbery, W. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6610 · Cited by 207 · cited 1× · see citing works
“The results have not been uniform; increases in Tau phosphorylation have been observed in some cases, not in others (Davis et al., 1997; Lovell et al., 2004; Su et al., 2010).”
ResultChronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells
Su, B., Wang, X., Lee, H., Tabaton, M., Perry, G. L., Smith, M. A., & Zhu, X. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.010 · Cited by 178 · cited 1× · see citing works
“The results have not been uniform; increases in Tau phosphorylation have been observed in some cases, not in others (Davis et al., 1997; Lovell et al., 2004; Su et al., 2010).”
ResultSwimming against the Tide: Mobility of the Microtubule-Associated Protein Tau in Neurons
Konzack, S., Thies, E., Marx, A., Mandelkow, E., & Mandelkow�, E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0927-07.2007 · Cited by 157 · cited 3× · see citing works
“This type of phosphorylation causes the detachment of Tau from microtubules, makes them dynamic, and renders Tau highly diffusible and able to enter dendrites (Konzack et al., 2007).”
BackgroundInfluentialSelf-citationSynaptic targeting by Aβ oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease
Klein, W. L. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.11.003 · Cited by 107 · cited 2× · see citing works
“Part of the problem is the definition of the toxic state of A , which may be monomeric, oligomeric (currently favored), or fibrillar (formerly favored) (Klein, 2006; Glabe, 2008; Roychaudhuri et al., 2009).”
BackgroundTimm, T., Balusamy, K., Li, X., Biernat, J., Mandelkow, E., & Mandelkow, E.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706596200 · Cited by 95 · cited 1× · see citing works
“…polyclonal amyloid- (Cell Signaling Technology; 1:200); mAb 12E8 (1:500); mAb AT8 (1:100); polyclonal MARK phospho-T208 [prepared as described by Timm et al. (2008); 1:100]; phosphop70S6Kinase (pT389, clone 108D2, Cell Signaling Technology; 1:50); polyclonal BRSK1 (Acris, 1:100); phospho-MAPK…”
Self-citationWhiteman, I. T., Gervasio, O. L., Cullen, K. M., Guillemin, G. J., Jeong, E. V., Witting, P. K., Antao, S. T., Minamide, L. S., Bamburg, J. R., & Goldsbury, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3531-09.2009 · Cited by 92 · cited 2× · see citing works
“…previously (Stamer et al., 2002; Hollenbeck and Saxton, 2005; Thies and Mandelkow, 2007), such mitochondrial traffic jams cause a local drop of energy (ATP) and consequently spine destruction through the perturbation of the actin network and loss of synaptic components (Whiteman et al., 2009).”
BackgroundMichaelis, M. L., Ansar, S., Chen, Y., Reiff, E. R., Seyb, K. I., Himes, R. H., Audus, K. L., & Georg, G. I. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.074450 · Cited by 91 · cited 1× · see citing works
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundPirttilä, T., Kim, K. S., Mehta, P. D., Frey, H., & Wı́sniewski, H. M. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90140-6 · Cited by 79 · cited 1× · see citing works
“1b), whereas the general A antibody 6E10 (Pirttilä et al., 1994; Jung et al., 1999) reacted independently of the medium.”
BackgroundTau phosphorylation and proteolysis: Insights and perspectives
Johnson, G. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s326 · Cited by 73 · cited 1× · see citing works
“With regard to proline-directed kinases we tested MAPK, JNK, cdk5, and GSK3b, all considered to be involved in the pathological phosphorylation of Tau (Johnson, 2006).”
MethodFalk, T., Zhang, S., & Sherman, S. J. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-49 · Cited by 71 · see citing works
Uboha, N. V., Flajolet, M., Nairn, A. C., & Picciotto, M. R. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0725-07.2007 · Cited by 71 · cited 1× · see citing works
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
BackgroundMattson, M. (1992) · Brain Research · doi:10.1016/0006-8993(92)90323-2 · Cited by 67 · cited 1× · see citing works
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundA high-affinity protein stain for western blots, tissue prints, and electrophoretic gels.
Bickar, D., & Reid, P. D. (1992) · Analytical Biochemistry · doi:10.1016/0003-2697(92)90049-d · Cited by 56 · cited 1×
“To confirm equal loading and successful blotting membranes were routinely stained using the CPTS staining method (Bickar and Reid, 1992), followed by standard Western blot procedure.”
MethodOxidative Stress Induces Dephosphorylation of τ in Rat Brain Primary Neuronal Cultures
Davis, D. R., Anderton, B., Brion, J., Reynolds, C., & Hanger, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68041590.x · Cited by 53 · see citing works
Minniti, A. N., Rebolledo, D. L., Grez, P. M., Fadić, R., Aldunate, R., Volitakis, I., Cherny, R. A., Opazo, C., Masters, C. L., Bush, A. I., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-2 · Cited by 46 · cited 1× · see citing works
“Glabe, University of California, Irvine, CA), that shows high specificity to amyloid oligomers (Kayed et al., 2007).”
BackgroundProteasome-mediated effects on amyloid precursor protein processing at the γ-secretase site
Flood, F., MURPHY, S., Cowburn, R. F., Lannfelt, L., Walker, B., & Johnston, J. A. (2005) · Biochemical Journal · doi:10.1042/bj20041145 · Cited by 40 · cited 1× · see citing works
“Proteasome activity was determined following (Flood et al., 2005).”
Axon degeneration: Mechanisms and implications of a distinct program from cell death
Yan, T., Feng, Y., & Zhai, Q. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.013 · Cited by 36 · cited 1× · see citing works
“Given this localized loss of microtubules, we hypothesized that this might lead to an impairment of mitochondrial trafficking with local dendritic energy deprivation (Yan et al., 2010).”
BackgroundCalmodulin Binding and Cdk5 Phosphorylation of p35 Regulate Its Effect on Microtubules*
He, L., Hou, Z., & Qi, R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706937200 · Cited by 33 · cited 1× · see citing works
“This could explain the increase in activity of MARK, cdk5 and others; for example, CaMK-I activates MARK2 and this pathway contributes to neuronal differentiation (Biernat et al., 2002; Uboha et al., 2007; He et al., 2008; Wu et al., 2010).”
Backgroundβ-Amyloid precursor protein is detectable on monocytes and is increased in Alzheimer’s disease
Jung, S. S., Gauthier, S. G., & Cashman, N. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00051-2 · Cited by 31 · cited 1× · see citing works
“1b), whereas the general A antibody 6E10 (Pirttilä et al., 1994; Jung et al., 1999) reacted independently of the medium.”
BackgroundFeinstein, S. (2005) · doi:10.3410/f.1024510.289727 · Cited by 17 · cited 1×
“Lowering cytosolic Ca 2 would appear as prime target for intervention, but the decay of microtubules seems more targetable through microtubulestabilizing drugs (Mattson, 1992; Michaelis et al., 2005; Zhang et al., 2005).”
BackgroundIn Search of the Molecular Basis of Memory Loss in Alzheimer Disease
Ashe, K. H. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213847.66742.d9 · Cited by 7 · cited 2× · see citing works
“We also note that in our preparations we did not consistently observe a band at 56 kDa, a species that has been reported to be toxic for transgenic mice (Lesné et al., 2006) but can be visualized in certain conditions (Walsh et al., 2005; Ashe, 2006; Bernstein et al., 2009).”
BackgroundS3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain
Tolnay, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2011.05.2444 · cited 2×
“, 2007), and indeed the Tau pathology correlates well with clinical symptoms (Braak and Braak, 1991; Clavaguera et al., 2009).”
Background
Flagged first, then by citations
3 of the 70 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Alzheimer's DiseasePreprint
Selkoe, D. J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004457 · Cited by 371 · see citing works
“Many studies employing supraphysiological concentrations of synthetic Ab peptides in oligomeric form (generally larger than dimers/ trimers) have also provided evidence of tau alteration (Zempel et al. 2010) and various neurotoxic effects.”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · see citing works
Bloom (2014) · doi:10.1001/jamaneurol.2013.5847 · Cited by 2,194 · see citing works
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251 · see citing works
Self-citationThe toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Benilova, I., Karran, E., & De Strooper, B. (2012) · Nature Neuroscience · doi:10.1038/nn.3028 · Cited by 1,962 · see citing works
Alzheimer Mechanisms and Therapeutic Strategies
Huang, Y., & Mucke, L. (2012) · Cell · doi:10.1016/j.cell.2012.02.040 · Cited by 1,758 · see citing works
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201 · see citing works
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118 · see citing works
“A recent report (Zempel et al., 2010) suggests that spines might serve as a site of convergence for amyloid beta and tau.”
BackgroundRoles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003 · see citing works
Neurotoxicity of Amyloid -Protein: Synaptic and Network Dysfunction
Mucke, L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006338 · Cited by 1,000 · see citing works
Morris, M., Maeda, S., Vossel, K., & Mucke, L. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.009 · Cited by 899 · see citing works
“Acute exposure of neuronal cultures to Ab led to hyperphosphorylation (De Felice et al., 2008) and mislocalization of tau into dendritic spines (Zempel et al., 2010), which, at least in some dendrites, was associated with spine collapse and dendritic degeneration.”
BackgroundInfluentialJin, M., Shepardson, N., Yang, T., Chen, G., Walsh, D., & Selkoe, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017033108 · Cited by 876 · see citing works
The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade
Cline, E. N., Bicca, M. A., Viola, K. L., & Klein, W. L. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179941 · Cited by 870 · see citing works
Biochemistry and Cell Biology of Tau Protein in Neurofibrillary DegenerationPreprint
Mandelkow, E., & Mandelkow, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006247 · Cited by 839 · see citing works
Self-citationHistory and progress of hypotheses and clinical trials for Alzheimer’s disease
Liu, P.-P., Xie, Y., Meng, X.-Y., & Kang, J.-S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0063-8 · Cited by 723 · see citing works
Interaction between Aβ and Tau in the Pathogenesis of Alzheimer’s Disease
Zhang, H., Wei, W., Zhao, M., Ma, L., Jiang, X., Pei, H., Cao, Y., & Li, H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57078 · Cited by 689 · see citing works
Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
Musiek, E. S., & Holtzman, D. M. (2015) · Nature Neuroscience · doi:10.1038/nn.4018 · Cited by 697 · see citing works
the Dominantly Inherited Alzheimer Network, Barthélemy, N. R., Li, Y., Joseph-Mathurin, N., Gordon, B. A., Hassenstab, J., Benzinger, T. L. S., Buckles, V., Fagan, A. M., Perrin, R. J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0781-z · Cited by 651 · see citing works
Amyloid β oligomers in Alzheimer’s disease pathogenesis, treatment, and diagnosis
Viola, K. L., & Klein, W. L. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1386-3 · Cited by 628 · see citing works
Arendt, T., Stieler, J. T., & Holzer, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.018 · Cited by 609 · see citing works
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600 · see citing works
The Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535 · see citing works
“Some experiments indicated that tau is normally highly enriched in axons relative to dendrites (Binder et al., 1985), but in response to Aβ is extensively redistributed into the somato-dendritic compartment (Delacourte et al., 1990; Zempel et al., 2010).”
BackgroundOligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease
Tu, S., Okamoto, S., Lipton, S. A., & Xu, H. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-48 · Cited by 582 · see citing works
“In cultured neurons, A β-induced tau hyperphosphorylation and dendritic disruption can be attenuated by anti-A β antibodies or tau reduction using RNAi-targeting strategies [128-130].”
Tau imaging: early progress and future directions
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70252-2 · Cited by 501 · see citing works
Morris, M., Knudsen, G. M., Maeda, S., Trinidad, J. C., Ioanoviciu, A., Burlingame, A. L., & Mucke, L. (2015) · Nature Neuroscience · doi:10.1038/nn.4067 · Cited by 472 · see citing works
The importance of tau phosphorylation for neurodegenerative diseases
Noble, W., Hanger, D. P., Miller, C. C. J., & Lovestone, S. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00083 · Cited by 475 · see citing works
“This in turn causes local elevations in Ca2+ and disruption of synaptic function through impaired trafficking and/or synaptic anchoring of glutamate receptors (3, 127, 128).”
BackgroundWu, T., Dejanovic, B., Gandham, V. D., Gogineni, A., Edmonds, R., Schauer, S., Srinivasan, K., Huntley, M. A., Wang, Y., Wang, T.-M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.060 · Cited by 466 · see citing works
Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration
Verma, M., Lizama, B. N., & Chu, C. T. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-021-00278-7 · Cited by 451 · see citing works
“It has also been suggested that mutations in presenilins affect intracellular calcium levels [132], and that elevations in intracellular calcium play key roles in promoting tau pathology [133] through activation of microtubule affinity-regulating kinase, cyclin-dependent kinase 5 or AMP-activated kinase [134].”
BackgroundInteractions of pathological proteins in neurodegenerative diseases
Spires‐Jones, T. L., Attems, J., & Thal, D. R. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1709-7 · Cited by 424 · see citing works
“Moreover, in cell culture experiments, applying exogenous Aβ to mouse primary neurons instigates τ phosphorylation and mislocalization to dendrites [163], and in human stem cell-derived neuronal cultures, overexpressing fAD mutations in APP and PS1 causes both plaque and tangle pathology [21].”
BackgroundThe dendritic tree and brain disorders
Kulkarni, V. A., & Firestein, B. L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.03.005 · Cited by 390 · see citing works
Tau Aggregation and Its Interplay with Amyloid-β
Nisbet, R. M., Polanco, J.-C., Ittner, L. M., & Götz, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1371-2 · Cited by 359 · see citing works
Ferreira, S. T., Lourenco, M. V., Oliveira, M. M., & De Felice, F. G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00191 · Cited by 373 · see citing works
“Zempel and collaborators have shown that AβOs induce tau missorting, a phenomenon in which axonal taumoves to dendrites in hyperphosphorylated form, disrupting cytoskeletal organization and axonal transport (Zempel et al., 2010), ultimately instigating neuronal collapse.”
BackgroundSoluble Aβ oligomer production and toxicity
Larson, M. E., & Lesné, S. E. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07478.x · Cited by 356 · see citing works
“1), 125–139 2011 The Authors (Zempel et al. 2010).”
InfluentialMairet-Coello, G., Courchet, J., Pieraut, S., Courchet, V., Maximov, A., & Polleux, F. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.003 · Cited by 351 · see citing works
“There is growing recognition that Ab42 oligomers induce Tau relocation from the axon to dendrites (Zempel et al., 2010), where it can act as a protein scaffold to facilitate the interaction of the Src kinase Fyn with NMDAR.”
InfluentialMolecular mechanisms of dendrite stability
Koleske, A. J. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3486 · Cited by 351 · see citing works
How does brain insulin resistance develop in Alzheimer's disease?
De Felice, F. G., Lourenco, M. V., & Ferreira, S. T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.004 · Cited by 337 · see citing works
“Another possibility is that excessive NMDAR activation and calcium influx triggered by oligomers [57,58,63,64] stimulate the activity of tyrosine phosphatases on IRS-1, as described for glutamate-induced neuronal damage [65], thus attenuating insulin signal transduction.”
Johnson, S. M., Connelly, S., Fearns, C., Powers, E. T., & Kelly, J. W. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.12.060 · Cited by 326 · see citing works
Alzheimer’s disease and insulin resistance: translating basic science into clinical applications
Felice, F. G. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64595 · Cited by 328 · see citing works
Chang, J., Liu, F., Lee, M., Wu, B. M., Ting, K., Zara, J., Soo, C., Hezaimi, K. A., Zou, W., Chen, X.-H., et al. (2013) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1300532110 · Cited by 317 · see citing works
GSK-3 and tau: a key duet in Alzheimer’s disease
Sayas, C. L., & Ávila, J. (2021) · Cells · doi:10.3390/cells10040721 · Cited by 314 · see citing works
“and is missorted from axons to the somatodendritic compartment, where it interferes with synaptic function [180,181].”
BackgroundReddy, P. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.052 · Cited by 300 · see citing works
“In another study, Zempel et al. (2010) investigated differentiated primary hippocampal neurons for early localized changes following exposure to Aβ oligomers.”
BackgroundMicrotubule-associated protein tau is essential for long-term depression in the hippocampus
Kimura, T., Whitcomb, D. J., Jo, J., Regan, P., Piers, T., Heo, S., Brown, C., Hashikawa, T., Murayama, M., Seok, H., et al. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0144 · Cited by 307 · see citing works
Bateman, R. J., Benzinger, T. L., Berry, S., Clifford, D. B., Duggan, C., Fagan, A. M., Fanning, K., Farlow, M. R., Hassenstab, J., McDade, E. M., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.07.005 · Cited by 303 · see citing works
Sydow, A., Van der Jeugd, A., Zheng, F., Ahmed, T., Balschun, D., Petrova, O., Drexler, D., Zhou, L., Rune, G., Mandelkow, E., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5245-10.2011 · Cited by 302 · see citing works
“The activity-dependent transport mechanism into spines may be altered in anti- and pro-aggregant animals because of TauRD missorting to somatodendritic compartments (Zempel et al., 2010).”
BackgroundSelf-citationSadleir, K. R., Kandalepas, P. C., Buggia-Prévot, V., Nicholson, D. A., Thinakaran, G., & Vassar, R. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1558-9 · Cited by 294 · see citing works
“S3), and that Aβ causes Tau to mis-sort into the dendrite [16,17].”
BackgroundApoptotic and non-apoptotic roles of caspases in neuronal physiology and pathophysiology
Hyman, B. T., & Yuan, J. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3228 · Cited by 249 · see citing works
Zempel, H., Luedtke, J., Kumar, Y., Biernat, J., Dawson, H., Mandelkow, E., & Mandelkow, E. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.207 · Cited by 283 · see citing works
“Light and electron microscopy set-ups, live-imaging conditions, photoconversion, and quantification procedures were described previously (Zempel et al , 2010; Li et al , 2011).”
InfluentialSelf-citationMolecular Pathogenesis of the Tauopathies
Götz, J., Halliday, G., & Nisbet, R. M. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012936 · Cited by 276 · see citing works
Dendritic Tau in Alzheimer’s Disease
Ittner, A., & Ittner, L. M. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.003 · Cited by 278 · see citing works
“Similarly, exposure to oligomeric Ab promotes levels of tau in dendrites (Figure 2B, e), contributing to the increased levels of tau in this compartment in AD (Zempel et al., 2010).”
BackgroundTracy, T. E., Sohn, P. D., Minami, S. S., Wang, C., Min, S.-W., Li, Y., Zhou, Y., Le, D., Lo, I., Ponnusamy, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.005 · Cited by 277 · see citing works
“In cultured neurons, mislocalization of an FTLD-tau mutant in postsynaptic spines depletes glutamate receptors (Hoover et al., 2010), and amyloid-b (Ab) oligomers induce missorting of tau into dendrites and spine retraction (Zempel et al., 2010).”
Physiological and pathological phosphorylation of tau by Cdk5
Kimura, T., Ishiguro, K., & Hisanaga, S. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00065 · Cited by 297 · see citing works
“…when neurons suffer from various neurotoxic insults, such as Aβ (Otth et al., 2002; Han et al., 2005; Zheng et al., 2005, 2010; Lopes et al., 2007; Zempel et al., 2010; Shukla et al., 2012), ischemia/hypoxia (Wen et al., 2007; Barros-Miñones et al., 2013), oxidative stress (Absalon et al.,…”
BackgroundTau-based therapies in neurodegeneration: opportunities and challenges
Li, C., & Götz, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.155 · Cited by 272 · see citing works
The role of type 2 diabetes in neurodegeneration
Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 276 · see citing works
Kopeikina, K. J., Carlson, G. A., Pitstick, R., Ludvigson, A. E., Peters, A., Luebke, J. I., Koffie, R. M., Frosch, M. P., Hyman, B. T., & Spires‐Jones, T. L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.004 · Cited by 272 · see citing works
Models of β-amyloid induced Tau-pathology: The long and “folded” road to understand the mechanism
Stancu, I.-C., Vasconcelos, B., Terwel, D., & Dewachter, I. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-51 · Cited by 256 · see citing works
“These include increased phosphorylation and cytoplasmic and dendritic translocation, often linked to neurodegeneration which was Tau or even P-Tau dependent [26-38].”
BackgroundLost after translation: missorting of Tau protein and consequences for Alzheimer disease
Zempel, H., & Mandelkow�, E. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.004 · Cited by 272 · see citing works
Self-citationMondragón-Rodríguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N., & Boehm, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401240 · Cited by 272 · see citing works
Protein phosphorylation in neurodegeneration: friend or foe?
Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252 · see citing works
“Therefore, MARKs may have regulatory functions in spine morphology and synaptic transmission, but may also act as critical mediators in Aβ-induced toxicity on synapses and dendritic spines (Zempel et al., 2010; Hayashi et al., 2011; Yu et al., 2012).”
BackgroundPathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242 · see citing works
Larson, M. E., Sherman, M. A., Amar, F., Nuvolone, M., Schneider, J. A., Bennett, D. A., Aguzzi, A., & Lesné, S. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1858-12.2012 · Cited by 274 · see citing works
“Following this initial report, several in vivo lines of evidence demonstrated that A , Fyn, and tau might constitute a deleterious triad in AD physiopathology (Chin et al., 2004, 2005; Ittner et al., 2010; Zempel et al., 2010; Roberson et al., 2011).”
BackgroundInfluentialRetractedThe Role of Cdk5 in Alzheimer’s Disease
Liu, S., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 273 · see citing works
“kinases, and finally, leading to neuronal loss [51, 52].”
BackgroundSoluble forms of tau are toxic in Alzheimer's disease
Kopeikina, K., Hyman, B., & Spires-Jones, T. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0032-y · Cited by 232 · see citing works
“Two families of protein kinases contribute to tau phosphorylation, those that are proline directed and tend to phosphorylate serine and threonine motifs outside the microtubule binding domain and those that are KXGS-motif and non-proline directed and tend to phosphorylate within the repeat domain [14, 31].”
InfluentialFluid biomarkers in Alzheimer’s disease – current concepts
Rosén, C., Hansson, O., Blennow, K., & Zetterberg, H. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-20 · Cited by 214 · see citing works
“They can inhibit hippocampal long-term potentiation in vivo [87], and cause abnormal tau phosphorylation and neuritic dystrophy [88-90].”
Ochalek, A., Mihalik, B., Avci, H. X., Chandrasekaran, A., Téglási, A., Bock, I., Giudice, M. L., Táncos, Z., Molnár, K., László, L., et al. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0317-z · Cited by 225 · see citing works
Tau in neurodegenerative disease
Gao, Y.-L., Wang, N., Sun, F.-R., Cao, X.-P., Zhang, W., & Yu, J.-T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.23 · Cited by 222 · see citing works
“In neurons which were acutely exposed to Aβ, Aβ initiated tau-mediated neurotoxicity by facilitating tau phosphorylation (60) and directing pathogenic tau species into dendritic spines (33), leading to spine collapse and dendritic degeneration.”
BackgroundSanchez-Varo, R., Trujillo-Estrada, L., Sanchez-Mejias, E., Torres, M., Baglietto-Vargas, D., Moreno-Gonzalez, I., De Castro, V., Jimenez, S., Ruano, D., Vizuete, M., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0896-x · Cited by 222 · see citing works
“Supporting the possible involvement of microtubule destabilization in AD pathogenesis, it has been recently reported [31] that natural oligomeric Ab, isolated from AD patients, disrupted the microtubule cytoskeleton and caused neuritic dystrophy (see also [67]).”
BackgroundCdk5: a multifaceted kinase in neurodegenerative diseases
Cheung, Z. H., & Ip, N. Y. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.003 · Cited by 233 · see citing works
Hong, S., Ostaszewski, B. L., Yang, T., O’Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., & Selkoe, D. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.027 · Cited by 213 · see citing works
Endoplasmic Reticulum Ca2+ Handling in Excitable Cells in Health and Disease
Stutzmann, G. E., & Mattson, M. P. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003814 · Cited by 250 · see citing works
Amyloid-Dependent and Amyloid-Independent Stages of Alzheimer Disease
Hyman, B. T. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.70 · Cited by 192 · see citing works
Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration
Li, X., Kumar, Y., Zempel, H., Mandelkow, E., Biernat, J., & Mandelkow, E. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.376 · Cited by 218 · see citing works
“The barrier breaks down when Tau is phosphorylated in its repeat domain and detached from microtubules, for example, by the kinase MARK/Par1.”
BackgroundInfluentialSelf-citationA role for tau at the synapse in Alzheimer’s disease pathogenesis
Pooler, A. M., Noble, W., & Hanger, D. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.018 · Cited by 203 · see citing works
“Cultured rat neurons treated with oligomeric Ab also displayed translocation of tau from the axonal compartment to dendrites with concurrent increase of tau phosphorylation at specific epitopes (Zempel et al., 2010).”
BackgroundChen, L.-L., Fan, Y.-G., Zhao, L.-X., Zhang, Q., & Wang, Z.-Y. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106301 · Cited by 200 · see citing works
Goure, W. F., Krafft, G. A., Jerecic, J., & Hefti, F. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt272 · Cited by 190 · see citing works
Caspase-2 cleavage of tau reversibly impairs memory
Zhao, X., Kotilinek, L. A., Smith, B., Hlynialuk, C., Zahs, K., Ramsden, M., Cleary, J., & Ashe, K. H. (2016) · Nature Medicine · doi:10.1038/nm.4199 · Cited by 187 · see citing works
Atypical, non-standard functions of the microtubule associated Tau protein
Sotiropoulos, I., Galas, M., Silva, J. M., Skoulakis, E. M. C., Wegmann, S., Maina, M. B., Blum, D. L., Sayas, C. L., Mandelkow, E., Mandelkow�, E., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0489-6 · Cited by 211 · see citing works
Self-citationUntangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease
Pereira, J. B., Janelidze, S., Ossenkoppele, R., Kvartsberg, H., Brinkmalm, A., Mattsson, N., Stomrud, E., Smith, R. A., Zetterberg, H., Blennow, K., et al. (2020) · Brain · doi:10.1093/brain/awaa395 · Cited by 201 · see citing works
“Although the associations revealed by these data are cross-sectional, the most likely interpretation based on previous animal studies (Zempel et al., 2010, 2013; Rozkalne et al., 2011; Cohen et al., 2013; Spires-Jones and Hyman, 2014; Koffie et al., 2019), is that amyloid-b deposition is followed…”
BackgroundResultPickett, E. K., Herrmann, A. G., McQueen, J., Abt, K., Dando, O., Tulloch, J., Jain, P., Dunnett, S., Sohrabi, S., Fjeldstad, M. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.044 · Cited by 179 · see citing works
“…Ab-mediated synaptic plasticity deficits, from studies indicating that dendritic tau mediates Ab synaptotoxicity, and from a study that found synaptic tau phosphorylation in APP/PS1 mice (Roberson et al., 2007, 2011; Shipton et al., 2011; Ittner et al., 2010; Zempel et al., 2010; Wu et al., 2018).”
BackgroundCrimins, J. L., Pooler, A. M., Polydoro, M., Luebke, J. I., & Spires‐Jones, T. L. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.03.002 · Cited by 161 · see citing works
Thornton, C., Bright, N. J., Sastre, M., Muckett, P. J., & Carling, D. (2011) · Biochemical Journal · doi:10.1042/bj20101485 · Cited by 183 · see citing works
Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease
Nand, S., Singh, C., Singh, A., Singh, M. P., & Singh, S. P. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01945-y · Cited by 213 · see citing works
Sohn, P. D., Tracy, T. E., Son, H.-I., Zhou, Y., Leite, R. E. P., Miller, B. L., Seeley, W. W., Grinberg, L. T., & Gan, L. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0109-0 · Cited by 160 · see citing works
Aβ-induced Golgi fragmentation in Alzheimer’s disease enhances Aβ production
Joshi, G., Chi, Y., Huang, Z.-P., & Wang, Y.-Z. (2014) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1320192111 · Cited by 169 · see citing works
“It has been proposed that Aβ can trigger Ca influx (23), which activates calpain, a Ca-dependent protease that cleaves p35 to produce p25 for cdk5 activation (24).”
BackgroundTau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
Guerrero-Muñoz, M. J., Gerson, J., & Castillo-Carranza, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00464 · Cited by 168 · see citing works
“…it is possible that a direct interaction between the two proteins may be involved in the induction of synaptic dysfunction as tau and Aβ coexist within synaptic compartments in AD brain (Hoover et al., 2010; Ittner et al., 2010; Zempel et al., 2010; Tai et al., 2012; Miller et al., 2014).”
BackgroundTau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β
Vossel, K. A., Xu, J. C., Fomenko, V., Miyamoto, T., Suberbielle, E., Knox, J. A., Ho, K., Kim, D. H., Yu, G.-Q., & Mucke, L. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201407065 · Cited by 167 · see citing works
“Tau has been implicated in A-induced cytoskeletal changes (King et al., 2006; Zempel et al., 2013), including deacetylation and polyglutamylation of tubulin and microtubule disassembly within dendrites of subpopulations of neurons (Zempel et al., 2010, 2013).”
Degradation of tau protein by autophagy and proteasomal pathways
Wang, Y., & Mandelkow, E. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120071 · Cited by 166 · see citing works
Self-citationSynaptic pathology: A shared mechanism in neurological disease
Henstridge, C. M., Pickett, E. K., & Spires‐Jones, T. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.005 · Cited by 172 · see citing works
“Treating primary neurons with physiological concentrations of amyloid-β induces synapse loss, which has recently been associated with tau mislocalization to dendrites [62].”
Role of Aβ in Alzheimer’s-related synaptic dysfunction
Zhang, H., Jiang, X., Ma, L., Wei, W., Li, Z., Chang, S., Wen, J., Sun, J., & Li, H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.964075 · Cited by 144 · see citing works
Castillo-Carranza, D. L., Guerrero-Muñoz, M. J., Sengupta, U., Hernandez, C., Barrett, A. D. T., Dineley, K., & Kayed, R. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4989-14.2015 · Cited by 149 · see citing works
“Moreover, this redistribution of tau seems to be responsible for spine loss (Zempel et al., 2010).”
BackgroundHuman neural stem cells alleviate Alzheimer-like pathology in a mouse model
Lee, I.-S., Jung, K., Kim, I., Lee, H.-J., Kim, M., Yun, S., Hwang, K., Shin, J. E., & Park, K. I. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0035-6 · Cited by 169 · see citing works
“Alternatively, the small decrease in Aβ levels observed in the present study may have affected levels of phosphorylated tau because Aβ directly precedes aberrant tau phosphorylation [54–56].”
Braak, H., & Del Tredici, K. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy152 · Cited by 148 · see citing works
Tammineni, P., Ye, X., Feng, T., Aikal, D., & Cai, Q. (2017) · eLife · doi:10.7554/elife.21776 · Cited by 169 · see citing works
“…the association of Ab oligomers with AVs in AD brains, we utilized the well-characterized A11 antibody that only recognizes soluble Ab oligomers, but not APP and its cleaved products C99, soluble monomer, or insoluble fibrils (Jimenez et al., 2008, 2011; Kayed et al., 2003; Zempel et al., 2010).”
MethodReduction of Nuak1 Decreases Tau and Reverses Phenotypes in a Tauopathy Mouse Model
Lasagna‐Reeves, C. A., de Haro, M., Hao, S., Park, J., Rousseaux, M. W. C., Al‐Ramahi, I., Jafar‐Nejad, P., Vilanova-Velez, L., See, L., Maio, A. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.09.022 · Cited by 156 · see citing works
Bukke, V. N., Moola, A., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 160 · see citing works
Iijima-Ando, K., Sekiya, M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B., & Iijima, K. M. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002918 · Cited by 142 · see citing works
“The reduction in mitochondria in the axon may be due to alterations in mitochondrial fission/fusion [3,5,6] and/or due to defects in the axonal transport of mitochondria [4,6,8,10–12].”
BackgroundThe Toxicity and Polymorphism of β-Amyloid Oligomers
Huang, Y., & Liu, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124477 · Cited by 168 · see citing works
Tau protein is essential for stress-induced brain pathology
Lopes, S., Vaz‐Silva, J., Pinto, V., Dalla, C., Kokras, N., Bedenk, B. T., Mack, N., Czisch, M., Almeida, O. F. X., Sousa, N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600953113 · Cited by 147 · see citing works
“Although Tau is found mainly in the neuronal axon and soma, previous work suggests that Tau is missorted and accumulated at synapses under pathological conditions (24, 28).”
BackgroundResultMillan, M. J. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.03.004 · Cited by 146 · see citing works
Ardiles, Á. O., Tapia‐Rojas, C., Mandal, M., Alexandre, F., Kirkwood, A., Inestrosa, N. C., & Palacios, A. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201209109 · Cited by 146 · see citing works
- Authors
- Zempel, H., Thies, E., Mandelkow, E., & Mandelkow, E.-M.
- Affiliations
- Max Planck Unit for Structural Molecular Biology (DE)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Mandelkow, Eva-Maria
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-09-08
- Volume
- 30
- Issue
- 36
- Pages
- 11938-11950
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6633549
- OpenAlex
- W2041956586
- Cited by
- 686
- References
- 70
- Citations by year
- 2026: 29 · 2025: 33 · 2024: 27 · 2023: 22 · 2022: 30 · 2021: 38 · 2020: 54 · 2019: 46 · 2018: 49 · 2017: 46 · 2016: 50 · 2015: 51 · 2014: 61 · 2013: 54 · 2012: 50
- FWCI
- 32.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- DZNE Pub (submittedVersion)
- Funders
- European Commission
- Deutsche Forschungsgemeinschaft
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta oligomers, Alzheimer's disease, tau phosphorylation, dendrites, microtubule destabilization, dendritic spines, neurofilaments, mitochondria, paclitaxel, p70S6K, cyclin-dependent kinase 5, hippocampal neurons, axonal transport, oxidative stress, glutamate, serum deprivation
- MeSH terms
- Adenosine Triphosphate, Analysis of Variance, Animals, Calcium, Cells, Cultured, Dendrites, Embryo, Mammalian, Hippocampus, L-Lactate Dehydrogenase, Microtubules, Mitochondria, Neurons, Peptide Fragments, Phosphorylation, Protein Kinases, Time Factors, Amyloid beta-Peptides, tau Proteins, Neurofilament Proteins, Rats, Sprague-Dawley, Protein Transport, Microscopy, Electron, Transmission, Dendritic Spines, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review